Sexual dimorphism in the response to N-methyl-D-aspartate receptor antagonists and morphine on behavior and c-Fos induction in the rat brain

Neuroscience

Volumn 93, Issue 4, 1999, Pages 1539-1547

  D'Souza, D N ^a   Harlan, R E ^a   Garcia, M M ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Immediate early genes; Morphine; NMDA receptor antagonists; Sex differences; Striatum; Thalamus

Indexed keywords

2 AMINO 4,5 (1,2 CYCLOHEXYL) 7 PHOSPHONOHEPTANOIC ACID; DIZOCILPINE; DIZOCILPINE MALEATE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN CORTEX; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; DRUG ANTAGONISM; FEMALE; GENE EXPRESSION; HYPERACTIVITY; IMMEDIATE EARLY GENE; IMMUNOCYTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN INDUCTION; PUTAMEN; RAT; SEX DIFFERENCE; SUBCUTANEOUS DRUG ADMINISTRATION; THALAMUS NUCLEUS;

AMINO ACIDS; ANIMALS; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GENES, IMMEDIATE-EARLY; MALE; MORPHINE; NARCOTICS; NEOSTRIATUM; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SEX CHARACTERISTICS; THALAMUS;

EID: 0032790254     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00229-8     Document Type: Article

References (58)

1. Akinci M.K., Johnston G.A. Sex differences in acute swim stress-induced changes in the binding of MK-801 to the NMDA subclass of glutamate receptors in mouse forebrain. J. Neurochem. 61:1993;2290-2293.
2. Ali B., Sharif H., Elkadi S.I. Sex differences and the effect of gonadectomy on morphine-induced antinociception and dependence in rats and mice. Clin. exp. Pharmac. Physiol. 22:1995;342-344.
3. Berendse H.W., Groenewegen H.J. Organization of the thalamostriatal projections in the rat, with special emphasis on the ventral striatum. J. comp. Neurol. 299:1990;187-228.
4. Blanchard D.C., Blanchard R.J., Carobrez A. de P., Veniegas R., Rodgers R.J., Shepherd J.K. MK-801 produces a reduction in anxiety-related antipredator defensiveness in male and female rats and a gender-dependent increase in locomotor behavior. Psychopharmacology. 108:1992;352-362.
5. Bobelis D.J., Balster R.L. Pharmacological specificity of the discriminative stimulus properties of 2-amino-4,5-(1,2-cyclohexyl)-7-phosphono-heptanoic acid (NPC 12626), a competitive N-methyl-D-aspartate receptor antagonist. J. Pharmac. exp. Ther. 264:1993;845-853.
6. Boeijinga P.H., Boddeke H.W. Activation of 5-HT1B receptors suppresses low but not high frequency synaptic transmission in the rat subicular cortex in vitro. Brain Res. 721:1996;59-65.
7. Boldry R.C., Papa S.M., Kask A.M., Chase T.N. MK-801 reverses effects of chronic levodopa on D1 and D2 dopamine agonist-induced rotational behavior. Brain Res. 692:1995;259-264.
8. Chang S.L., Squinto S.P., Harlan R.E. Morphine activation of c-Fos expression in rat brain. Biochem. biophys. Res. Commun. 157:1988;698-704.
9. Cicero T.J., Nock B., Meyer E.R. Sex-related differences in morphine's antinociceptive activity: relationship to serum and brain morphine concentrations. J. Pharmac. exp. Ther. 282:1997;939-944.
10. Dall'olio R., Rimodini R., Gandolfi O. Effects of competitive and non-competitive NMDA receptor antagonists on behavioral responses induced by 7-OH-DPAT and quinpirole in rats. Pharmac. Res. 36:1997;203-209.
11. Druhan J.P., Rajabi H., Stewart J. MK-801 increases locomotor activity without elevating extracellular dopamine levels in the nucleus accumbens. Synapse. 24:1996;135-146.
12. D'Souza D. N., Harlan R. E. and Garcia M. M. (1998) Gonadal hormones, glutamate receptors and morphine-induced immediate early genes in the rat brain. Expl Biol. Abstr. 2659.
13. Ferkany J.W., Hamilton G.S., Patch R.J., Huang Z., Borosky S.A., Bednar D.L., Jones B.E., Zubrowski R., Willetts J., Karbon E.W. Pharmacological profile of NPC 17742 [2R,4R,5S-(2-amino-4,5-(1,2-cyclohexyl)-7-phosphonoheptanoic acid)], a potent, selective and competitive N-methyl-D-aspartate receptor antagonist. J. Pharmac. exp. Ther. 264:1993;256-264.
14. Gandolfi O., Rimondini R., Dall'Olio R. The modulation of dopaminergic transmission in the striatum by MK-801 is independent of presynaptic mechanisms. Neuropharmacology. 31:1992;1111-1114.
15. Garcia M.M., Brown H.E., Harlan R.E. Alterations in immediate-early gene proteins in the rat forebrain induced by acute morphine injection. Brain Res. 692:1995;23-40.
16. Groenewegen H.J., Berendse H.W. The specificity of the 'nonspecific' midline and intralaminar thalamic nuclei. Trends Neurosci. 17:1994;52-57.
17. Harlan R.E., Garcia M.M. Drugs of abuse and immediate-early genes in the forebrain. Molec. Neurobiol. 16:1998;221-267.
18. Hiramatsu M., Cho A.K., Nabeshima T. Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine. Eur. J. Pharmac. 166:1989;359-366.
19. Hoffman D.C., Donovan H., Cassella J.V. The effects of haloperidol and clozapine on the disruption of sensorimotor gating induced by noncompetitive, glutamate antagonist MK-801. Psychopharmacology. 111:1993;339-344.
20. Honack D., Loscher W. Sex differences in NMDA receptor mediated responses in rats. Brain Res. 620:1993;167-170.
21. Irifune M., Shimizu T., Nomoto M., Fukuda T. Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonists-induced hyperlocomotion in mice. Pharmac. Biochem. Behav. 51:1995;291-296.
22. Islam A.K., Cooper M.L., Bodnar R.J. Interactions among aging, gender, and gonadectomy effects upon morphine antinociception in rats. Physiol. Behav. 54:1993;45-53.
23. Iversen S.D. 5-HT and anxiety. Neuropharmacology. 23:1984;1553-1560.
24. Kabuto H., Yokoi I., Mizukawa K., Mori A. Effects of an N-methyl-D-aspartate receptor agonist and its antagonist CPP on the levels of dopamine and serotonin metabolites in rat striatum collected in vivo by using a brain dialysis technique. Neurochem. Res. 14:1989;1075-1080.
25. Kantak K.M., Edwards M.A., O'Connor T.P. Modulation of the discriminative stimulus and rate-altering effects of cocaine by competitive and noncompetitive N-methyl-D-aspartate antagonists. Pharmac. Biochem. Behav. 59:1998;159-169.
26. Kavaliers M., Galea L.A. Sex differences in the expression and antagonism of swim stress-induced analgesia in deer mice vary with the breeding season. Pain. 63:1995;327-334.
27. Kavaliers M., Innes D.G. Developmental changes in opiate-induced analgesia in deer mice: sex and population differences. Brain Res. 516:1990;326-331.
28. Kepler K.L., Kest B., Kiefel J.M., Cooper M.L., Bodnar R.J. Roles of gender, gonadectomy and estrous phase in the analgesic effects of intracerebroventricular morphine in rats. Pharmac. Biochem. Behav. 34:1989;119-127.
29. Limonta P., Maggi R., Dondi D., Martini L., Piva F. Gonadal steroid modulation of brain opioid systems. J. Steroid Biochem. 27:1987;691-698.
30. Liu F.C., Nickolenko J., Sharp F.R. Morphine induces c-Fos and jun-B in striatum and nucleus accumbens via D1 and N-methyl-D-aspartate receptors. Proc. natn. Acad. Sci. U.S.A. 91:1994;8537-8541.
31. Lodge D., Johnson K.M. Noncompetitive excitatory amino acid receptor antagonists. Trends pharmac. Sci. 11:1990;81-86.
32. Loscher W., Annies R., Honack D. The N-methyl-D-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats. Neurosci. Lett. 128:1991;191-194.
33. Loscher W., Annies R., Honack D. Comparison of competitive and uncompetitive NMDA receptor antagonists with regard to monoaminergic neuronal activity and behavioral effects in rats. Eur. J. Pharmac. 242:1993;263-274.
34. Loscher W., Honack D. The behavioral effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems. Eur. J. Pharmac. 215:1992;199-208.
35. Mansour A., Fox C.A., Burke S., Meng F., Thompson R.C., Akil H., Watson S.J. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J. comp. Neurol. 350:1994;412-438.
36. Mansour A., Fox C.A., Thompson R.C., Akil H., Watson S.J. Mu-opioid receptor mRNA expression in the rat CNS: comparison to mu-receptor binding. Brain Res. 643:1994;245-265.
37. Mansour A., Valenstein E.S. Morphine responsiveness and seizure proneness. Expl Neurol. 85:1984;346-357.
38. Maura G., Guadagnin A., Raiteri M. Low nanomolar serotonin inhibits the glutamate receptor/nitric oxide/cyclic GMP pathway in slices from adult rat cerebellum. Neuroscience. 68:1995;455-463.
39. Maura G., Raiteri M. Serotonin 5-HT1D and 5-HT1A receptors respectively mediate inhibition of glutamate release and inhibition of cyclic GMP production in rat cerebellum in vitro. J. Neurochem. 66:1996;203-209.
40. McDonald J.W., Silverstein F.S., Cardona D., Hudson C., Chen R., Johnston M.V. Systemic administration of MK-801 protects against N-methyl-D-aspartate- and quisqualate-mediated neurotoxicity in perinatal rats. Neuroscience. 36:1990;589-599.
41. Mogil J.S., Sternberg W.F., Kest B., Marek P., Liebeskind J.C. Sex differences in the antagonism of swim stress-induced analgesia: effects of gonadectomy and estrogen replacement. Pain. 53:1993;17-25.
42. Moskowitz A.S., Goodman R.R. Light microscopic autoradiographic localization of mu and delta opioid binding sites in the mouse central nervous system. J. Neurosci. 4:1984;331-1342.
43. Nankai M., Fage D., Carter C. Striatal NMDA receptor subtypes: the pharmacology of N-methyl-D-aspartate-evoked dopamine, gamma-aminobutyric acid, acetylcholine and spermidine release. Eur. J. Pharmac. 286:1995;61-70.
44. Nath C., Gupta M.N., Patnaik G.K., Dhawan K.N. Morphine-induced straub tail response: mediated by central mu2-opioid receptor. Eur. J. Pharmac. 263:1994;203-205.
45. Pauwels P.J. 5-HT 1B/D receptor antagonists. Gen. Pharmac. 29:1997;293-303.
46. Quirion R., Zajac J.M., Morgat J.L., Roques B.P. Autoradiographic distribution of mu and delta opiate receptors in rat brain using highly selective ligands. Life Sci. 33:(Suppl. 1):1983;227-230.
47. Sharif N.A., Hughes J. Discrete mapping of brain mu and delta opioid receptors using selective peptides: quantitative autoradiography, species differences and comparison with kappa receptors. Peptides. 10:1989;499-522.
48. Sheng M., Greenberg M.E. The regulation and function of c-fos and other immediate early genes in the nervous system. Neuron. 4:1990;477-485.
49. Tricklebank M.D. The behavioral response to 5-HT receptor agonists and subtypes of the central 5-HT receptor. Trends pharmac. Sci. 6:1985;403-407.
50. Tricklebank M.D., Forler C., Fozard J.R. The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioral response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat. Eur. J. Pharmac. 106:1984;271-282.
51. Tricklebank M.D., Singh L., Oles R.J., Wong E.H., Iversen S.D. A role for receptors of N-methyl-D-aspartic acid in the discriminative stimulus properties of phencyclidine. Eur. J. Pharmac. 141:1987;497-501.
52. Tzschentke T.M., Schmidt W.J. Morphine-induced catalepsy is augmented by NMDA receptor antagonists, but is partially attenuated by an AMPA receptor antagonist. Eur. J. Pharmac. 295:1996;137-146.
53. Verma A., Moghaddam B. NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine. J. Neurosci. 16:1996;373-379.
54. Whitton P.S., Biggs C.S., Pearce B.R., Fowler L.J. MK-801 increases extracellular 5-hydroxytryptamine in rat hippocampus and striatum in vivo. J. Neurochem. 58:1992;1573-1575.
55. Wiley J.L., Cristello A.F., Balster R.L. Effects of site-selective NMDA receptor antagonists in an elevated plus-maze model of anxiety in mice. Eur. J. Pharmac. 294:1995;101-107.
56. Willets J., Balster R.L., Leander J.D. The behavioral pharmacology of N-methyl-D-aspartate antagonists. Trends pharmac. Sci. 11:1990;423-428.
57. Willins D.L., Narayanan S., Wallace L.J., Uretsky N.J. The role of dopamine and AMPA/kainate receptors in the nucleus accumbens in the hypermotility response to MK-801. Pharmac. Biochem. Behav. 46:1993;881-887.
58. Wintrip N., Nance D.M., Wilkinson M. Sexually dimorphic MK-801-induced c-Fos in the rat hypothalamic paraventricular nucleus. Neurosci. Lett. 242:1998;151-154.